Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Topline results from the phase 3 ATTAIN-MAINTAIN trial showed orforglipron met the primary end point of superior percent maintenance of body weight reduction compared with placebo
These outcomes are linked to coordinated appetite suppression and metabolic rate modulation
Your provider will help choose the right medication based on health history and goals
The outer FedEx package contained a temperature-controlled insulated bag, and both ice packs inside were still frozen solid when the delivery arrived
PubMed laboratory research record [PMID: 34706925] PubMed record related to this compound for laboratory literature review
US$ 26.46
US$ 24.39
US$ 24.59
US$ 26.13
US$ 20.05
US$ 27.62
US$ 29.65
